Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPEC with mitomycin C during surgery for locally advanced colorectal cancer
2015-001801-15Phase 3Active
- Sponsor
- FIBICO
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mitomycin c in colorectal cancer (CRC) (2 arms), sponsored by FIBICO. Primary endpoint: Locoregional control. Started Oct 2015; status: active.
02
Drugs
mitomycin c
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2015-001801-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001801-15.